| Net Cash Provided by (Used in) Operating Activities |
-194K |
USD |
-46.8% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
194K |
USD |
+46.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
132M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-4 |
USD |
-33.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
1.61M |
USD |
+10.3% |
Q4 2024 |
FY 2024 |
| Depreciation |
125 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
1.5K |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
1.61M |
USD |
+10.3% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
2 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
10.2M |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
2 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |